title: Prevention of gastric cancer by Helicobacter pylori eradication.
abstract: The evidence supporting the important role of Helicobacter pylori causing gastric cancer is getting stronger. The mechanisms by which H. pylori can influence the progression to severe changes in the gastric mucosa are under investigation. An increased gastric epithelial cell proliferation has been observed in individuals infected with H. pylori. This lifelong increased cell turnover is deemed to be a major risk factor for increased mutational changes and may lead to the development of gastric cancer. Successful eradication of H. pylori infection induces the healing of the gastritis and a significant decrease in gastric epithelial cell proliferation. Nevertheless, it is right now unknown at which time the point of no return, meaning at which time an eradication therapy leads to a benefit for the individual to prevent gastric cancer, has been reached. Therefore the major question that arises is to whom an eradication therapy should be offered to prevent gastric cancer. A general elimination of the infection might be worthwhile, but seems to be unrealistic now because of the high prevalence of the infection and the missing of a vaccine. This review reflects possible mechanisms of gastric cancer development induced by chronic H. pylori infection and recent investigational trials for prevention of gastric cancer by H. pylori eradication therapy will be discussed.
authors.affiliation: Department of Gastroenterology and Hepatology, Otto von Guericke University Magdeburg, Magdeburg, Germany. Andreas.Leodolter@medizin.uni-magdeburg.de
authors.forename: A
authors.initials: A
authors.lastname: Leodolter
authors.forename: M
authors.initials: M
authors.lastname: Naumann
authors.forename: P
authors.initials: P
authors.lastname: Malfertheiner
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D018450:Disease Progression; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000472:pathogenicity; D006801:Humans; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents